3 Takeaways from ISPE Boston’s 2022 Product Show

Posted by Laura Berberian
On September 29, 2022

With the annual ISPE Boston Product Show behind us, the Product Show Committee chairs (Victor Taubinger and Laura Berberian) want to take a minute to reflect on some of the highlight’s from this year’s show: 1. Most well attended show ~ The Product Show opened for registration in early August and attendees started rolling in. […]

Pretzel Therapeutics Launches to Pioneer Mitochondrial Therapies

Posted by ISPE Boston
On September 22, 2022

Pretzel Therapeutics has launched with a $72.5 million Series A financing to pioneer novel therapies to modulate mitochondrial function. “We are excited to pioneer a new era in the treatment of diseases related to mitochondrial dysfunction. The expertise we have assembled and the platform technologies we have created will allow new inroads into treating both […]

Photys Therapeutics Debuts

Posted by ISPE Boston
On September 22, 2022

Founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women’s Hospital and the Broad Institute of MIT and Harvard, Cambridge-based Photys Therapeutics has launched with $75 million Series A funding. Photyx is advancing phosphorylation inducing chimeric small molecules (PHICS), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to […]

Gingko Bioworks Exec Renee Wegrzyn to Lead New Federal Agency

Posted by ISPE Boston
On September 22, 2022

President Biden has appointed Renee Wegrzyn, PhD, as the first Director of the Advanced Research Projects Agency for Health (ARPA-H). Dr. Wegrzyn is currently the Vice President for Business Development at Ginkgo Bioworks. ARPA-H was established in March 2022 to drive transformative health breakthroughs that cannot readily be accomplished through traditional research or commercial activity. […]

Congratulations to Jim Grunwald, Hank Moes Award Winner!

Posted by ISPE Boston
On September 15, 2022

Jim Grunwald has a consistent, long-standing, and extraordinary legacy of supporting ISPE, specifically the Boston Area Chapter. As an ISPE member for over 30 years, Jim was instrumental in ushering in the modern-day version of the ISPE Boston Area Chapter, the largest and most successful chapter in ISPE. His contributions include President of the Board […]

Congratulations to the Women in Pharma Committee, Outstanding Achievement Award Winner

Posted by ISPE Boston
On September 14, 2022

The Women in Pharma Committee (WIP) is deserving of the outstanding achievement award for many reasons. Despite the challenges of COVID, they have found many ways to bring people together in safe, comfortable, and fun formats. WIP, under the guidance of Caren Jenkins and Yolanda McClean, successfully presented the following innovative events: Golf clinics to […]

Congratulations to Eric Felz, Our Volunteer of the Year Award Winner!

Posted by ISPE Boston
On September 13, 2022

I have worked in a few different industries and have found that the life science industry is incredibly collaborative in discussing best practices and use cases. While many other industries are worried about competition and IP, Life science is sharing stories to help all companies bring life-saving treatments and cures to patients. ISPE is a […]

Product Show 30th Anniversary

Posted by ISPE Boston
On September 12, 2022

30 Years of the Product Show and so many memories. Check out the photos we have collected from the past shows, find you and your friends in these photos and relive the fun times before we make new memories at the upcoming 2022 Product Show!

In Reversal, Amylyx ALS Drug Receives FDA Advisory Committee Support

Posted by ISPE Boston
On September 9, 2022

Amylyx Pharmaceuticals announced today that the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted 7 to 2 that the available evidence of effectiveness is sufficient to support approval of the drug the company has developed for the treatment of ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease. The committee’s decision was […]

MassBio Reports MA Biopharma Raised $5.1 Billion

Posted by ISPE Boston
On September 8, 2022

The 2022 Industry Snapshot newly released by the Massachusetts Biotechnology Council (MassBio) shows significant growth across the life sciences industry in 2021 in both workforce and real estate and reveals resilience in the face of some notable headwinds. Venture capital funding of the biopharma industry remains strong in 2022 despite a downturn in biopharma stock […]

Page 29 of 117«‹27 282930 31 ›»